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Abstract
Introduction: Our aim was to investigate the impact of early versus late initiation of renal replacement therapy
(RRT) on clinical outcomes in critically ill patients with acute kidney injury (AKI).
Methods: Systematic review and meta-analysis were used in this study. PUBMED, EMBASE, SCOPUS, Web of Science
and Cochrane Central Registry of Controlled Clinical Trials, and other sources were searched in July 2010. Eligible studies
selected were cohort and randomised trials that assessed timing of initiation of RRT in critically ill adults with AKI.
Results: We identified 15 unique studies (2 randomised, 4 prospective cohort, 9 retrospective cohort) out of 1,494
citations. The overall methodological quality was low. Early, compared with late therapy, was associated with a
significant improvement in 28-day mortality (odds ratio (OR) 0.45; 95% confidence interval (CI), 0.28 to 0.72). There
was significant heterogeneity among the 15 pooled studies (I
2 = 78%). In subgroup analyses, stratifying by patient
population (surgical, n = 8 vs. mixed, n = 7) or study design (prospective, n = 10 vs. retrospective, n = 5), there was
no impact on the overall summary estimate for mortality. Meta-regression controlling for illness severity (Acute
Physiology And Chronic Health Evaluation II (APACHE II)), baseline creatinine and urea did not impact the overall
summary estimate for mortality. Of studies reporting secondary outcomes, five studies (out of seven) reported
greater renal recovery, seven (out of eight) studies showed decreased duration of RRT and five (out of six) studies
showed decreased ICU length of stay in the early, compared with late, RRT group. Early RRT did not; however,
significantly affect the odds of dialysis dependence beyond hospitalization (OR 0.62 0.34 to 1.13, I
2 = 69.6%).
Conclusions: Earlier institution of RRT in critically ill patients with AKI may have a beneficial impact on survival. However,
this conclusion is based on heterogeneous studies of variable quality and only two randomised trials. In the absence of
new evidence from suitably-designed randomised trials, a definitive treatment recommendation cannot be made.
Introduction
Acute kidney injury (AKI) is a serious complication of cri-
tical illness that is associated with substantial morbidity
and mortality [1-7]. Extracorporeal renal replacement
therapy (RRT) has long been used as supportive treatment
of AKI, and has traditionally focused on averting the life-
threatening derangements associated with kidney failure
(that is, metabolic acidosis, hyperkalemia, uremia, and/or
fluid overload) while allowing time for organ recovery.
Observations from a large multinational, multicenter sur-
v e yf o u n dt h ep r e v a l e n c eo fs e v e r eA K Is u p p o r t e dw i t h
RRT in critically ill patients was approximately 6% [7].
A critical decision in the support of critically ill
patients with AKI is when to initiate RRT. Data have
emerged to suggest that earlier RRT initiation may
attenuate kidney-specific and non-kidney organ injury
from acidemia, uremia, fluid overload, and systemic
inflammation [8,9]. This in turn, may potentially
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any medium, provided the original work is properly cited.translate into improved survival and earlier recovery of
kidney function [9]. Unfortunately, in the absence of
refractory acidemia, toxic hyperkalemia and intravascu-
lar fluid overload contributing to respiratory failure,
there is limited evidence to guide clinicians on when to
initiate RRT in critically ill patients with AKI. The ques-
tion of timing of initiation of RRT (that is, “early” versus
“late”) has seldom been the focus of high-quality or rig-
orous evaluation [10-23]. As a consequence, initiatives
aimed at identifying the “optimal timing of initiation of
RRT” in AKI have been given the highest priority for
investigation by the Acute Kidney Injury Network
(AKIN) [24,25].
Accordingly, we conducted a systematic review and
meta-analysis to determine whether “early” versus “late”
initiation of RRT in critically ill patients with AKI is
associated with a survival benefit or more favourable
renal recovery.
Materials and methods
This study was conducted and reported according to
PRISMA guidelines [26] (Additional File 1).
Search strategy
We performed a comprehensive search of MEDLINE
(1985 to July 2010), PubMed, EMBASE (1985 to July
2010), the Cochrane Central Registry of Controlled
Trials, Web of Science, and Scopus to identify rando-
mised trials and cohort studies that assessed the timing
of initiation of RRT in critically ill patients with AKI.
We restricted our search to clinical studies performed
in adult populations and published in the English lan-
guage. We also excluded studies published prior to
1985 largely to reflect important advances in RRT tech-
nology and in critical care support not available in older
studies.
We extended our search to include clinical trial regis-
tries (Controlled trials metaRegister) and review of
abstracts from selected scientific proceedings (Society of
Critical Care Medicine, European Society of Intensive
Care Medicine and American Society of Nephrology).
The bibliographies of all retrieved articles were also
hand-searched.
Our search was based on four search themes using the
Boolean operator ‘OR’ (Additional File 2). The first Boo-
lean heading included keyword/MESH headings describ-
ing RRT and its different modalities. The second
Boolean heading employed terms describing AKI. The
third Boolean heading combined the keywords/MESH
headings related to critical illness and its different popu-
lations. The fourth Boolean search included terms
describing timing or initiation of therapy. The searches
were combined by using the Boolean term “AND”.
Study selection
Two reviewers (CK and MF/IS/SM) independently per-
formed an initial eligibility screen of all retrieved titles
and abstracts (when available). Those studies reporting
original data that specifically mentioned the application
of RRT in patients with AKI were selected for further
review. Full-text review was independently performed by
two reviewers (as above) for the following specific elig-
ibility criteria: 1) observational cohort and/or rando-
mised/quasi-randomised clinical trial (RCT) design; 2)
adult critically ill population; 3) diagnosis of AKI; 4)
description of factors related to timing of initiation of
RRT; and 5) description of mortality and/or clinically
relevant secondary outcomes (that is, kidney recovery
and/or dialysis independence, duration of RRT, and ICU
length of stay).
Disagreements between reviewers were resolved by a
third reviewer or by discussion and consensus.
Data extraction
All data were extracted independently with standardised
forms with subsequent discussion of any discrepancies.
Data were collected on study characteristics and quality,
demographics and baseline characteristics (that is, clini-
cal/biochemical parameters at initiation of RRT), and
details of RRT modality (that is, continuous venovenous
hemofiltration (CVVH), continuous venovenous hemo-
dialysis (CVVHD), continuous venovenous hemodiafil-
tration (CVVHDF), and intermittent hemodialysis
(IHD)). The primary outcome measure was mortality.
Secondary outcomes included: kidney recovery and/or
dialysis independence, duration of RRT and ICU length
of stay.
Assessment of methodological quality
Randomised studies were appraised using a modified
version of the Jadad score [27]. Evaluation of cohort stu-
dies was done in a descriptive fashion similar to pre-
vious studies [28], incorporating the reported criteria for
RRT initiation, assembly of control groups, comparabil-
ity of intervention/control arms (that is, baseline charac-
teristics, severity of illness, dialysis modality), and a
description of dropouts.
Data analysis and assessment for bias
Data were analysed by STATA version 11 (StataCorp,
College Station, TX. USA) and Comprehensive Meta-
analysis version 2 (Biostat I n c . ,E n g l e w o o d ,N J ,U S A )
[29]. We assessed and quantified statistical heterogeneity
for each pooled summary estimate using Cochran’sQ
statistic and the I
2 statistic, respectively [30]. Pooled
analysis was performed using the DerSimonian and
Laird random effects model and reported as OR with
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assess for possible sources of heterogeneity according to
the following pre-defined variables: criteria used to initi-
ate RRT (that is, creatinine, urea, or other), severity of
illness (Acute Physiology and Chronic Health (APACHE
II) score), type of critical care unit (mixed medical/sur-
gical vs. surgical alone), and study design (observational
vs. RCT). Publication bias was assessed using Egger’s
regression model, and visualised with a funnel plot [31].
Results
Trial selection
A total of 1,494 citations were identified (Figure 1).
After primary and secondary screen, 15 studies fulfilled
all criteria for final analysis (13 articles and 2 abstracts).
Trial characteristics
We found two randomised trials [10,32], four prospec-
tive cohort studies [21,33-35], and nine retrospective
cohort studies [13,15,36-42]. Of these, 13 were pub-
lished as articles in peer-reviewed journals and 2 studies
were published as abstracts only [33,35]. Eight studies
examined only patients with surgical diagnoses (that is,
cardiac, abdominal, and trauma) while the remaining
seven studies were from mixed medical/surgical ICUs.
Assessment of trial quality
Of the two included RCTs, one fulfilled all quality indi-
cators [10] (Table 1), whereas the other did not describe
the methods of randomisation or perform analysis by
intention to treat [32]. Of the 13 cohort studies, none
fulfilled all quality indicators (Table 2). Only five had a
prospectively assembled control group [21,33-35,41],
four had comparable modes of RRT between the early
and late initiation groups [15,38,39,41], and only three
studies accounted for withdrawals/loss to follow-up
[34,35,38].
Type of renal replacement therapy and criteria used for
Continuous renal replacement therapy (CRRT) was used
as the principle modality for RRT in eight studies
[10,13,15,32,33,38,39,41], while a combination of IHD
a n dC R R Tw e r eu s e di nt h er e m a i n i n gs t u d i e s
[21,34-37,40,42] (Table 3). Six studies defined timing of
initiation of RRT based on cut-offs in serum urea
[15,21,34,35,37,42], two studies based on cut-offs in
serum creatinine [33,41], one study based on the Risk,
Injury, Failure, Loss, End-stage (RIFLE) criteria [3], and
four based on urine output [10,32,38,40]. Three other
studies used a composite of factors to designate early
initiation [13,36,39]. Eight studies reported duration of
RRT [10,13,15,33,34,38-40] (range 1 to 20 days). Seven
studies described recovery of kidney function (RRT
independence) [10,15,32,34,35,39,41].
Mortality
The OR for 28-day mortality is shown in Figure 2.
Overall 28-day mortality across the 15 trials was 53.3%
(1,431/2,684). Early RRT initiation was associated with
reduced mortality compared to late initiation (pooled
OR 0.45; 95% CI, 0.28 to 0.72, P < 0.001). However,
there was significant statistical heterogeneity (I
2 = 78%,
Q 63.7).
Figure 1 Outline of study selection process.
Table 1 Summary of quality indicators and validity
assessment of randomised trials fulfilling inclusion
criteria
Randomised control trials Bouman
[10]
Sugahara
[32]
Was the study described as randomised? Yes Yes
Was the method used to randomise described
and appropriate (table of random numbers,
computer generated, and so on)?
Yes No
Was there a description of withdrawals and
dropouts?
Yes Yes
Was there intention to treat analysis? Yes No
Were control and intervention group
comparable with respect to disease type and
demographics?
Yes No
Were the control and intervention groups
comparable with respect to disease severity?
Yes Yes
Was dialysis type comparable between groups
in terms of dose, solution used, filtration vs
dialysis, and type of membrane?
Yes Yes
Karvellas et al. Critical Care 2011, 15:R72
http://ccforum.com/content/15/1/R72
Page 3 of 10Subgroup analysis was performed according to type of
ICU (mixed vs. surgery only; Figure 3). The overall effect
estimate of the surgical group (OR 0.31, 95% CI 0.16 to
0.58, n = 8) was not statistically different than that of the
mixed group (OR 0.71, 95% CI 0.40 to 1.24, n = 7) with a
P-value of 0.06. There was also no statistical difference in
the overall effect estimates between prospective and ret-
rospective studies. There was also no statistically signifi-
cant effect on the pooled OR for mortality when analysed
according to baseline APACHE II scores, creatinine, and
urea levels. Therefore, meta-regression analyses with
these variables could not account for the large amounts
of heterogeneity observed.
Secondary outcomes
Five studies [15,32,34,39,41] (of seven reporting data)
described a higher rate of kidney recovery to dialysis inde-
pendence at hospital discharge for patients receiving early
RRT (Table 4). Pooled analysis of these seven studies
showed a non-significant summary estimate favouring
early RRT (OR 0.62, 95% CI 0.34 to 1.13, I
2 = 69.6%;
Figure 4).
Due to the variability in the reporting of the remain-
ing secondary outcomes of interest and evidence of sig-
nificant statistical heterogeneity, we did not perform a
pooled analysis for RRT duration or ICU length of stay.
Rather, we present the data on these secondary out-
comes descriptively (Table 4). Seven studies [10,13,15,
33,34,39,40] (of eight reported data) described shorter
duration of RRT in those receiving early RRT. Five
studies [13,35,37-39] (of six reported data) described a
reduction in ICU length of stay in those receiving early
RRT.
Publication bias
We assessed for publication bias using Egger’s linear
regression test and found statistical evidence of bias
(beta-coefficient of the bias estimate = -3.19, 95% CI =
-4.58 to -1.81, P = 0.0003). There appears to be publica-
tion bias towards smaller studies reporting positive
Table 2 Summary of quality indicators of non-randomised studies fulfilling inclusion criteria
Observational Study Sabater
[33]
Bagshaw
[34]
Gettings
[15]
Elahi
[38]
Demirkilic
[13]
Liu
[21]
Andrade
[36]
Wu
[42]
Manche
[40]
Iyem
[39]
Shiao
[41]
Carl
[37]
Bagshaw
[35]
Were criteria for
initiation of RRT
clearly defined in
each group?
Yes Yes Yes Yes Yes Yes No Yes No Yes Yes Yes Yes
Was the
measurement of
criterion (or lab
value) for initiation
of RRT reliable?
Yes Yes Yes Yes Yes Yes No Yes No No Yes Yes Yes
Was control group
prospectively
assembled? (vs
historical, or case-
control)
Yes Yes No No No Yes No No No No Yes No Yes
Were control and
intervention group
comparable with
respect to disease
type and
demographics?
No No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Were the control and
intervention group
comparable with
respect to disease
severity?
No No Yes Yes Yes No Yes Yes No Yes Yes Yes Yes
Was dialysis type
comparable between
groups in terms of
dose, solution used,
filtration vs dialysis,
and type of
membrane?
No No Yes Yes No No No No No Yes Yes No No
Was there a
description of
withdrawals and
dropouts?
No Yes No Yes No No No No No No No No Yes
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Author: Year Study design Population Modality Early
(n)
Late
(n)
Early criteria Late criteria
Bouman
[10]
2002 Randomised Cardiac surgery/
medical
CVVH 35 36 RRT within 12 hours if Urine
Output <30 ml/hr
Urea >40 mmol/l or K
>6.5 mmol/L
Sugahara
[32]
2004 Randomised Cardiac Surgery CVVH 14 14 Urine Output <20 ml/hr Urine Output <30 cc/hr
Liu [21] 2006 Prospective
Cohort
Medical,Surgery CRRT/IHD 122 121 Urea <27.1 mmol/L Urea >27.1 mmol/L
Sabater
[33]
2008 Prospective
Cohort
Medical (Septic
Shock)
CVVHF 9 23 Rifle Criteria (Risk, Injury)* Rifle Criteria (Failure)**
Bagshaw
[34]
2009 Prospective
Cohort
Medical, Surgical CRRT/IHD 618 619 Urea <24.2 mmol/L Urea >24.2 mmol/L
Bagshaw
[35]
2010 Prospective
Cohort
Medical, Surgical CRRT/IHD 117 117 Urea <23 mmol/L Urea >23 mmol/L
Gettings
[15]
1999 Retrospective
Cohort
Trauma CAVHD and
CVVHD
41 59 Urea <21.4 mmol/L Urea >21.4 mmol/L
Elahi [38] 2004 Retrospective
Cohort
Cardiac surgery CVVH 28 36 Urine Output <100 cc in 8 hrs K >6 mmol/L, Cr >250
mmol/L
Dermirkilic
[13]
2004 Retrospective
Cohort
Cardiac Surgery CVVHDF 27 34 Cr >400 μmol/L, Potassium >5.5
mmol/L
Oliguria
Andrade
[36]
2007 Retrospective
Cohort
Medical (ARDS/
Sepsis)
IHD/SLED 18 15 On admission At 24 hours
Wu [42] 2007 Retrospective
Cohort
Surgical ALF IHD/CVVH 54 26 Urea < 28.6 mmol/L Urea >28.6 mmol/L
Manche
[40]
2008 Retrospective
Cohort
Cardiac Surgery IHD 56 15 Hyperkalemia U/O <0.5 ml/kg/hour
Iyem [39] 2009 Retrospective
Cohort
Cardia Surgery CVVH 95 90 RRT on admission After 48 hours when
anuric
Shiao [41] 2009 Retrospective
Cohort
Surgery/Trauma CVVH 51 47 Rifle Criteria (Risk)* Rifle Injury, Failure**
Carl [37] 2010 Retrospective
Cohort
Medical (sepsis) CRRT/IHD 85 62 Urea <35.7 mmol/l Urea >35.7 mmol/L
Abbreviations: Cr = creatinine (μmol/L); K = potassium (mmol/L).
RIFLE Criteria Risk: Increase in serum Creatinine by 1.5 times or urine output <0.5 ml/kg/hour × 6 hours.
RIFLE Criteria Injury: Increase in serum Creatinine by 2 times or urine output <0.5 ml/kg/hour × 12.
RIFLE Criteria Failure: Increase in serum Creatinine by 3 times or urine output <0.3 ml/kg/hour × 24.
Figure 2 Forest plot of all 15 studies (Random Effects Model, OR, 95% CI).
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Table 4 Baseline characteristics and outcomes in intervention and control groups in 14 studies included in meta-
analysis
Author: Year Creatinine* Urea* APACHE II score Dialysis-
Free (%)
Duration of
RRT (days)
ICU Length of
Stay (days)
Mortality at 28-
days (%)
Early Late Early Late Early Late Early Late Early Late Early Late Early Late
Bouman [10] 2002 5 (4)
**
6 (4)
**
NR NR 21.7(5.5) 23.6(8.3) 17 22 5.7 6.6 NR NR 11/35 9/36
Sugahara [32] 2004 256 265 NR NR 19(2) 18(3) 10 2 NR NR NR NR 2/14 12/14
Liu [21] 2006 301 415 16.9 41.0 NR NR NR NR NR NR NR NR 43/122 50/121
Sabater [33] 2008 NR NR NR NR 24(8) 29(9) NR NR 6 7 NR NR 1/9 16/23
Bagshaw [34] 2009 230 396 15.0
(5.4)
38.8 (12) 11.1 (3)
§ 10.7 (3)
§ 91 74 4 (2-
13)
6 (2-
15)
13 (7-
24)
13 (6-
28)
392/
618
380/
619
Bagshaw [35] 2010 273 489 13.5 38.0 31(9.3) 28.1(6.7) 22 30 NR NR 12 14 67/117 54/117
Gettings [15] 1999 148 238 15.2
(4.6)
33.7 (10) NR NR 16 11 17.7 20.2 NR NR 25/41 47/59
Elahi [38] 2004 328 379 23.9 (12) 26.8 (22) NR NR NR NR 4.61 4.57 8.5 12.5 8/28 12/36
Dermirkilic
[13]
2004 NR NR NR NR NR NR NR NR 4.32 4.56 7.8 12.4 8/27 15/34
Andrade [36] 2007 583 548 73.9
(6.6)
82.8
(6.9)
24.5
(1.4)
26 (1.2) NR NR NR NR 20 13.6 3/18 10/15
Wu [42] 2007 256 415 16.5 (7) 42.4 (12) 18.2
(5.1)
20.5
(5.3)
NR NR NR NR NR NR 34/54 22/26
Manche [40] 2008 233 404 14.4
(3.1)
35.2 (18) NR . NR NR 1.8 6.5 NR NR 14/56 13/15
Iyem [39] 2009 186 256 19.5
(2.7)
24.3
(1.9)
NR . 95 87 1.6 4.1 2 4 5/95 6/90
Shiao [41] 2009 292 336 24.6 (14) 29.2 (14) 18.2
(5.4)
18.8
(6.3)
21 10 NR NR NR NR 22/51 35/47
Carl [37] 2010 442 514 23.6
(7.2)
48.9 (10) 24.8
(6.2)
24.7
(6.1)
NR NR NR NR 27 39.1 44/85 42/62
* Continuous variables reported as means and standard deviations when given.
** Bouman et al. reported creatinine clearance (ml/minute).
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initiation of RRT) (Figure 5).
Discussion
This systematic review and meta-analysis of 15 unique
studies compared “early” versus “late” initiation of RRT
in critically ill patients with AKI and suggests that ear-
lier initiation is associated with improved survival. There
is insufficient evidence to conclude that kidney recovery
to dialysis independence is influenced by the timing of
RRT initiation.
To our knowledge, this is the first systematic review to
address the question of whether timing of RRT initiation
has an important impact on survival and kidney recov-
ery in the critically ill. Previous work on this issue was
not specifically focused on critically ill patients sup-
ported in an ICU environment [43]. Moreover, in con-
trast to previous work [43], we intentionally excluded
older studies (that is, published before 1985) due to the
considerable advances in available technology for pro-
viding RRT, the marked demographic transition criti-
cally ill populations (that is, older, more comorbid
illness, receiving more complex procedures/interven-
tions), and the evolution in general of interventions and
technology available to support the critically ill. Accord-
ingly, our systematic review is uniquely focused on how
the timing of initiation of RRT impacts survival and kid-
ney recovery in modern ICU practice. Despite these
strengths, inferences from our study are limited for two
important reasons. First, we found significant statistical
heterogeneity. As such, we were unable to calculate
effect sizes for all secondary outcomes of interest. We
Figure 4 Forest plot of seven studies reported RRT independence (OR, 95% CI).
Figure 5 Funnel plot of all 15 studies. X-axis is log of risk ratio of
death. Y-axis is Standard error of Log Risk ratio of death. Egger’s
regression (plot not shown): Bias (intercept) -3.19736, P-value =
0.00025 (null hypothesis stating no small study effects is REJECTED).
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ity between published studies in study design and qual-
i t y ,w h i c hw ew e r eu n a b l et oa c c o u n tf o ri ns e n s i t i v i t y
analyses. Second, we found evidence of publication bias
towards smaller studies where early initiation of RRT
was associated with a survival benefit. As a consequence,
the magnitude of the pooled effect estimate may over-
state the `true` benefit, if any, of early compared with
late RRT initiation.
Our findings are broadly consistent with those reported
previously [43]. However, our study more specifically
focused on the critically ill and benefited from the recent
publication of several additional studies. In a previous
meta-analysis [43], Seabra and colleagues explored het-
erogeneity but found no association between effect esti-
mate and date of publication, RRT modality, sample size,
duration of study follow-up, and study quality. Likewise,
we could not account for the observed heterogeneity by
meta-regression according to patient and population
characteristics including type of ICU, severity of illness
(baseline APACHE II scores), and metabolic derange-
ments (baseline creatinine and urea levels). Accordingly,
the heterogeneity observed is most likely explained by
differences in study design (that is, clinical trial vs. cohort
study), operational definitions for RRT timing (that is,
clinical vs. biochemical criteria) and the inability to
account for heterogeneity in clinical practice patterns.
Our study has several notable strengths compared to ear-
lier work. First, we have included eight additional clinical
studies [32-35,37,39-41]. Second, we excluded studies for
which there was no comparable control group [44-46], as
well as older studies that have no applicability to current
ICU practice [11,16,22]. Third, we have found evidence
of publication bias and explain how older reports from
smaller studies favouring early RRT may have influenced
our summary estimates.
The utilization of RRT in critically ill patients with AKI
is relatively common [7,47]. Importantly, the incidence is
increasing [48]. These critically ill patients have a risk of
death approaching 60% [2,7]. The decision to initiate
RRT is a modifiable intervention for these patients; how-
ever, it also represents a significant escalation in the com-
plexity and cost of their support. The current uncertainty
over the optimal time to initiate RRT is a critical knowl-
edge gap in evidence that has almost certainly contribu-
ted to the wide variation in clinical practice. Moreover,
this has been further compounded by a lack of consensus
and a standardised definition for “early” RRT [24]. There
are currently numerous clinical, biochemical, and physio-
logical factors that are considered when deciding to initi-
ate RRT; however, there remains no consensus guidelines
or rigorous evidence to guide clinicians on this important
issue [24]. This is analogous to the uncertainty regarding
the optimal dose-intensity of RRT in critically ill patients
with AKI that was largely settled by the recent publica-
tion of two large randomised trials [49,50]. A future ran-
domised trial will ideally require broad-based consensus
on eligibility criteria and operational definitions for ‘early’
and ‘standard’ initiation of RRT in critically ill patients to
ensure feasibility and adequate separation of treatment
arms. In addition, such a study may benefit from the inte-
gration of novel kidney-injury specific biomarkers to aid
in the prediction of those who will develop worsening
AKI. Understanding methods to further optimise the
delivery of acute RRT for critically ill patients with AKI is
of utmost importance to improve patient outcomes,
guide resource utilization, and rationally deliver standar-
dised care.
Conclusions
In summary, our systematic review suggests that early
institution of RRT in critically ill patients with AKI may
have a measurable benefit on survival. However, existing
evidence is based on mostly smaller studies with impor-
tant differences in design and quality, and only two ran-
domised trials. In the absence of novel evidence from a
multi-centric suitably-designed randomised trial, conclu-
sive treatment recommendations on the optimal time to
initiate RRT remain uncertain. Future investigation
must be targeted at defining acceptable “early” RRT cri-
teria and determining whether “early” initiation of RRT,
compared with the current standard-of-care, has an
important modifying influence on short- and long-term
survival and kidney recovery.
Key messages
￿ The overall design and quality of studies compar-
ing early versus late initiation of RRT in critically ill
patients with AKI is low.
￿ Earlier initiation of RRT in critically ill patients
with AKI may have a beneficial impact on survival.
￿ A well-designed randomised trial targeting accepta-
ble ‘early’ compared with “standard” criteria for RRT
initiation in homogenous patient populations is
needed to definitively determine the effect of RRT
timing on patient outcomes.
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